Home / Fact sheets / Rwanda / Cervical qualitative data
Check also the following factsheets: Rwanda, Breast, Colorectal
Country fact sheet: Rwanda
CERVICAL CANCER SCREENING PROGRAMME
Reporting year for qualitative data: | 2020 |
Source of qualitative data: | Directly from Programme |
There is a pilot project:
|
Organization of screening | |
An individual/team/institution responsible to coordinate the programme: | Yes |
Dedicated budget for screening programme: | Yes |
Documented cancer screening policy: | Yes |
Nature of documentation of the policy: | Notification |
Year programme was initiated: | 2013 |
Programme introduction was preceded by a pilot: | No |
Screening tests provided free of charge: | Yes |
Diagnostic tests provided free of charge: | No |
Treatment services provided free of charge: | No |
Information system and data collection | |
System that collects data: | Individual & Aggregated |
• Identification of eligible population: | No |
• Screening participation: | Aggregated |
• Screening test results: | Individual & Aggregated |
• Further assessment: | No |
• Final pathology diagnosis: | Individual & Aggregated |
• Cancer staging: | No |
• Treatment: | Individual & Aggregated |
The information system exists at national or sub-national level: | Individual: Sub-national Aggregated: National |
The information system collects data outside the programme (opportunistic screening/private sector): | Yes |
Cancer screening data is linked with population-based cancer registry (PBCR): | No |
Screening protocol | |
A screening protocol or guideline: | Yes |
Year of published/updated protocol: | 2020 |
Target age (min-max) and screening interval [months] for each test: | HPV (30-49 years / [36 months]) VIA (30-49 years / [36 months]) |
Triaging test used: | VIA |
Self-collection HPV recommended: | No |
"Screen and treat" included in the protocol: | Yes |
Treatment modality for "screen and treat": | Thermal ablation LLETZ/CKC |
Invitations for screening and further assessment | |
Initiatives to create population awareness by the Health Ministry/Health Authority: | Mass media campaign Small media campaign Group education One-on-one education Dedicated website |
Invitations to eligible population: | No |
Source of the eligible individuals identified: | - |
Method of invitation: | - |
Screening kit included with the invitation: | - |
Screen positive individuals actively contacted for further assessment: | Yes |
Individuals with a precancer or cancer diagnosis actively contacted: | Yes |
Quality Assurance (QA) of screening activities | |
Documented standard operating procedure/policy for QA: | No |
An individual/team/institution responsible for QA: | Yes |
Accreditation of lab services: | Yes |
Accreditation of pathology services: | No |
Documented performance indicators: | No |
Reference standards for performance indicators: | - |
Evaluation reports published in the last five years: | No |
Performance indicators | |
Reporting year for quantitative data: | 2020 |
Source of quantitative data: | Pilot project |
Age range and regional limitation if applicable: | 30-49 years |
Invitation coverage (%): | |
Participation rate (%): | |
Examination coverage (%): | 21.6 |
Completeness of data related to screening test results (%): | 92.7 |
Completeness of data related to further assessment results (%): | |
Further assessment (Colposcopy referral) rate (%): | |
Further assessment participation rate (%): | |
Detection rate for CIN2+ (x 1000): | |
Detection rate for CIN3+ (x 1000): | |
Detection rate for invasive cancer (x 1000): | 0.8 |
Positive Predictive Value of abnormal screening test to detect CIN2+ (x 1000): | |
Positive Predictive Value for CIN3+ (x 1000): | |
Positive Predictive Value for invasive cancer (x 1000): | |
More quantitative data for a pilot project (2020/HPV) |
Check also the following factsheets: Rwanda, Breast, Colorectal